PMID- 32756811 OWN - NLM STAT- MEDLINE DCOM- 20210610 LR - 20210610 IS - 1809-452X (Electronic) IS - 1516-4446 (Print) IS - 1516-4446 (Linking) VI - 43 IP - 3 DP - 2021 May-Jun TI - Influence of migration on the thought process of individuals at ultra-high risk for psychosis. PG - 285-288 LID - 10.1590/1516-4446-2019-0685 [doi] AB - OBJECTIVE: To assess the influence of migration on the psychopathological presentation of individuals at ultra-high risk for psychosis (UHR) in Sao Paulo, Brazil. METHODS: This study is part of the Subclinical Symptoms and Prodromal Psychosis (SSAPP) project, a cohort study in Sao Paulo, Brazil, designed to follow individuals at UHR. After screening with the Prodromal Questionnaire (PQ) and a clinical interview, the Global Assessment of Functioning (GAF) was administered, a neuropsychological assessment was performed, sociodemographic and migration data were obtained. We then analyzed UHR individuals who had migration data to see if migration had any effect on their cognition and psychopathology. Chi-square tests were used for categorical variables, and Student's t test or analysis of variance (ANOVA) were used for nonparametric and parametric distributions, respectively. RESULTS: The sample was composed of 42 at-risk subjects, of whom 5 had a migration history in the past two generations. Those with migration history showed significantly more formal thought disturbances (p = 0.012) and sleeping problems (p = 0.033) compared to those without. CONCLUSIONS: Our data reinforce migration as a risk factor for psychosis in developing countries as well, and highlights the importance of studying the specific effect of this factor in UHR psychopathology. FAU - Nogueira, Arthur S AU - Nogueira AS AUID- ORCID: 0000-0003-2553-8360 AD - Laboratorio de Neurociencias (LIM 27), Instituto de Psiquiatria, Hospital das Clinicas, Faculdade de Medicina, Universidade de Sao Paulo (USP), Sao Paulo, SP, Brazil. FAU - Andrade, Julio C AU - Andrade JC AD - Laboratorio de Neurociencias (LIM 27), Instituto de Psiquiatria, Hospital das Clinicas, Faculdade de Medicina, Universidade de Sao Paulo (USP), Sao Paulo, SP, Brazil. FAU - Serpa, Mauricio H AU - Serpa MH AD - Laboratorio de Neurociencias (LIM 27), Instituto de Psiquiatria, Hospital das Clinicas, Faculdade de Medicina, Universidade de Sao Paulo (USP), Sao Paulo, SP, Brazil. AD - Instituto Nacional de Biomarcadores em Neuropsiquiatria (INBION), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Sao Paulo, SP, Brazil. AD - Laboratorio de Neuroimagem (LIM-21), Departamento e Instituto de Psiquiatria, Hospital das Clinicas, Faculdade de Medicina, USP, Sao Paulo, SP, Brazil. FAU - Alves, Tania M AU - Alves TM AD - Laboratorio de Neurociencias (LIM 27), Instituto de Psiquiatria, Hospital das Clinicas, Faculdade de Medicina, Universidade de Sao Paulo (USP), Sao Paulo, SP, Brazil. FAU - Freitas, Elder L AU - Freitas EL AD - Laboratorio de Neurociencias (LIM 27), Instituto de Psiquiatria, Hospital das Clinicas, Faculdade de Medicina, Universidade de Sao Paulo (USP), Sao Paulo, SP, Brazil. FAU - Hortencio, Lucas AU - Hortencio L AD - Laboratorio de Neurociencias (LIM 27), Instituto de Psiquiatria, Hospital das Clinicas, Faculdade de Medicina, Universidade de Sao Paulo (USP), Sao Paulo, SP, Brazil. FAU - van de Bilt, Martinus T AU - van de Bilt MT AD - Laboratorio de Neurociencias (LIM 27), Instituto de Psiquiatria, Hospital das Clinicas, Faculdade de Medicina, Universidade de Sao Paulo (USP), Sao Paulo, SP, Brazil. AD - Instituto Nacional de Biomarcadores em Neuropsiquiatria (INBION), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Sao Paulo, SP, Brazil. FAU - Rossler, Wulf AU - Rossler W AD - Laboratorio de Neurociencias (LIM 27), Instituto de Psiquiatria, Hospital das Clinicas, Faculdade de Medicina, Universidade de Sao Paulo (USP), Sao Paulo, SP, Brazil. AD - Instituto Nacional de Biomarcadores em Neuropsiquiatria (INBION), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Sao Paulo, SP, Brazil. AD - Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zurich, Switzerland. AD - Department of Psychiatry and Psychotherapy, Charite University of Medicine, Berlin, Germany. FAU - Gattaz, Wagner F AU - Gattaz WF AD - Laboratorio de Neurociencias (LIM 27), Instituto de Psiquiatria, Hospital das Clinicas, Faculdade de Medicina, Universidade de Sao Paulo (USP), Sao Paulo, SP, Brazil. AD - Instituto Nacional de Biomarcadores em Neuropsiquiatria (INBION), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Sao Paulo, SP, Brazil. FAU - Loch, Alexandre A AU - Loch AA AUID- ORCID: 0000-0002-0006-8107 AD - Laboratorio de Neurociencias (LIM 27), Instituto de Psiquiatria, Hospital das Clinicas, Faculdade de Medicina, Universidade de Sao Paulo (USP), Sao Paulo, SP, Brazil. AD - Instituto Nacional de Biomarcadores em Neuropsiquiatria (INBION), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Sao Paulo, SP, Brazil. LA - eng PT - Journal Article PL - Brazil TA - Braz J Psychiatry JT - Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) JID - 100895975 SB - IM MH - Brazil/epidemiology MH - Cohort Studies MH - Humans MH - Neuropsychological Tests MH - Prodromal Symptoms MH - Psychiatric Status Rating Scales MH - *Psychotic Disorders/diagnosis/epidemiology MH - Risk Factors MH - *Schizophrenia PMC - PMC8136387 COIS- The authors report no conflicts of interest. EDAT- 2020/08/07 06:00 MHDA- 2021/06/11 06:00 PMCR- 2020/08/03 CRDT- 2020/08/07 06:00 PHST- 2019/08/28 00:00 [received] PHST- 2020/03/13 00:00 [accepted] PHST- 2020/08/07 06:00 [pubmed] PHST- 2021/06/11 06:00 [medline] PHST- 2020/08/07 06:00 [entrez] PHST- 2020/08/03 00:00 [pmc-release] AID - S1516-44462020005024202 [pii] AID - 10.1590/1516-4446-2019-0685 [doi] PST - ppublish SO - Braz J Psychiatry. 2021 May-Jun;43(3):285-288. doi: 10.1590/1516-4446-2019-0685.